Literature DB >> 31529091

Dietary Choline or Trimethylamine N-oxide Supplementation Does Not Influence Atherosclerosis Development in Ldlr-/- and Apoe-/- Male Mice.

Paulina Aldana-Hernández1, Kelly-Ann Leonard1, Yuan-Yuan Zhao1, Jonathan M Curtis1, Catherine J Field1, René L Jacobs1,2.   

Abstract

BACKGROUND: Choline, an essential nutrient, is required for cell membranes, lipoprotein secretion, and methyl-group metabolism. Recently, it has been proposed that excess dietary choline consumption is metabolized to trimethylamine (TMA) by the gut microbiota; TMA is then oxidized to trimethylamine N-oxide (TMAO) in the liver. Epidemiological studies have clearly shown a positive correlation between plasma TMAO concentrations and cardiovascular events. Furthermore, some studies have shown an association between excess dietary choline, plasma TMAO concentrations, and atherosclerotic lesion size in apoE knockout (Apoe-/-) mice.
OBJECTIVE: The aim of this study was to further investigate the relation between dietary choline and atherosclerosis in 2 atherogenic mouse models, the LDL receptor knockout (Ldlr-/-) and Apoe-/- mice.
METHODS: Six feeding trials were performed in Ldlr-/- (40% high-fat diet) and Apoe-/- (unpurified diet) male mice, aged 8-10 wk. Mice randomly received control diet (0.1% choline), or choline- (1% choline), betaine- (0.1% choline and 0.9% betaine), or TMAO- (0.1% choline and 0.12% or 0.2% TMAO) supplemented diet for ≤28 wk. After the dietary intervention, the animals were killed and tissues and blood collected. Aortic atherosclerotic plaque area, plasma lipids, and choline metabolites were quantified.
RESULTS: In Ldlr-/- mice, dietary supplementation for 8 wk with choline or TMAO increased plasma TMAO concentrations by 1.6- and 4-fold, respectively. After 16 wk, there was a 2-fold increase in plasma TMAO after dietary TMAO supplementation. In Apoe-/- mice, dietary supplementation with choline, betaine, or TMAO for 12 wk did not increase plasma TMAO concentrations. However, choline and TMAO supplementation for 28 wk significantly increased plasma TMAO concentrations by 1.8- and 1.5-fold, respectively. Contrary to predictions, atherosclerotic lesion size was not altered by any of the dietary interventions, irrespective of mouse model.
CONCLUSIONS: In our study, high intakes of dietary choline or TMAO supplementation did not influence atherosclerosis development in Ldlr-/- or Apoe-/- male mice.
Copyright © American Society for Nutrition 2019.

Entities:  

Keywords:  zzm321990 Apoe−/− mice; zzm321990 Ldlr−/− mice; atherosclerosis; choline; trimethylamine N-oxide

Year:  2020        PMID: 31529091     DOI: 10.1093/jn/nxz214

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  27 in total

Review 1.  Short chain fatty acids and methylamines produced by gut microbiota as mediators and markers in the circulatory system.

Authors:  Maksymilian Onyszkiewicz; Kinga Jaworska; Marcin Ufnal
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-16

Review 2.  Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications.

Authors:  Monika Gawałko; Thomas A Agbaedeng; Arnela Saljic; Dominik N Müller; Nicola Wilck; Renate Schnabel; John Penders; Michiel Rienstra; Isabelle van Gelder; Thomas Jespersen; Ulrich Schotten; Harry J G M Crijns; Jonathan M Kalman; Prashanthan Sanders; Stanley Nattel; Dobromir Dobrev; Dominik Linz
Journal:  Cardiovasc Res       Date:  2022-08-24       Impact factor: 13.081

Review 3.  Targeting Trimethylamine N-Oxide: A New Therapeutic Strategy for Alleviating Atherosclerosis.

Authors:  Lele Jing; Honghong Zhang; Qiannan Xiang; Liang Shen; Xiaoxia Guo; Changlin Zhai; Huilin Hu
Journal:  Front Cardiovasc Med       Date:  2022-06-13

4.  Choline Supplementation Does Not Promote Atherosclerosis in CETP-Expressing Male Apolipoprotein E Knockout Mice.

Authors:  Heidi L Collins; Steven J Adelman; Dustie N Butteiger; Jonathan D Bortz
Journal:  Nutrients       Date:  2022-04-15       Impact factor: 6.706

Review 5.  Gut Microbiota and Cardiovascular Disease.

Authors:  Marco Witkowski; Taylor L Weeks; Stanley L Hazen
Journal:  Circ Res       Date:  2020-07-30       Impact factor: 17.367

Review 6.  How the immune system shapes atherosclerosis: roles of innate and adaptive immunity.

Authors:  Payel Roy; Marco Orecchioni; Klaus Ley
Journal:  Nat Rev Immunol       Date:  2021-08-13       Impact factor: 108.555

7.  Plasma levels of trimethylamine-N-oxide can be increased with 'healthy' and 'unhealthy' diets and do not correlate with the extent of atherosclerosis but with plaque instability.

Authors:  Yen Chin Koay; Yung-Chih Chen; Jibran A Wali; Alison W S Luk; Mengbo Li; Hemavarni Doma; Rosa Reimark; Maria T K Zaldivia; Habteab T Habtom; Ashley E Franks; Gabrielle Fusco-Allison; Jean Yang; Andrew Holmes; Stephen J Simpson; Karlheinz Peter; John F O'Sullivan
Journal:  Cardiovasc Res       Date:  2021-01-21       Impact factor: 10.787

8.  Circulating Levels of Muscle-Related Metabolites Increase in Response to a Daily Moderately High Dose of a Vitamin D3 Supplement in Women with Vitamin D Insufficiency-Secondary Analysis of a Randomized Placebo-Controlled Trial.

Authors:  Lise Sofie Bislev; Ulrik Kræmer Sundekilde; Ece Kilic; Trine Kastrup Dalsgaard; Lars Rejnmark; Hanne Christine Bertram
Journal:  Nutrients       Date:  2020-05-04       Impact factor: 5.717

9.  TMAO, a seafood-derived molecule, produces diuresis and reduces mortality in heart failure rats.

Authors:  Marta Gawrys-Kopczynska; Marek Konop; Klaudia Maksymiuk; Katarzyna Kraszewska; Ladislav Derzsi; Krzysztof Sozanski; Robert Holyst; Marta Pilz; Emilia Samborowska; Leszek Dobrowolski; Kinga Jaworska; Izabella Mogilnicka; Marcin Ufnal
Journal:  Elife       Date:  2020-06-08       Impact factor: 8.140

Review 10.  Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis.

Authors:  Yarong Liu; Min Dai
Journal:  Mediators Inflamm       Date:  2020-02-17       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.